0000899243-17-024434.txt : 20171018
0000899243-17-024434.hdr.sgml : 20171018
20171018182059
ACCESSION NUMBER: 0000899243-17-024434
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171016
FILED AS OF DATE: 20171018
DATE AS OF CHANGE: 20171018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COWAN D J PAUL E
CENTRAL INDEX KEY: 0001226486
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36415
FILM NUMBER: 171143375
MAIL ADDRESS:
STREET 1: 11000 WESTON PARKWAY
STREET 2: SUITE 100
CITY: CARY
STATE: NC
ZIP: 27513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quotient Ltd
CENTRAL INDEX KEY: 0001596946
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 264719797
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
BUSINESS PHONE: 41274832286
MAIL ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-16
0
0001596946
Quotient Ltd
QTNT
0001226486
COWAN D J PAUL E
28 ESPLANADE
ST. HELIER
Y9
JE2 3QA
JERSEY
1
1
0
0
See Remarks
Ordinary Shares
26666
D
Ordinary Shares
2017-10-16
4
S
0
30197
4.92
D
3228312
I
By spouse
Ordinary Shares
2017-10-17
4
S
0
45000
4.55
D
3183312
I
By spouse
Ordinary Shares
2017-10-18
4
S
0
24803
4.46
D
3158509
I
By spouse
Employee Stock Option (right to buy)
11.92
2026-05-31
Ordinary Shares
35000
35000
D
Multi-year Performance Based Restricted Stock Units
2018-12-31
Ordinary Shares
42000
42000
D
Multi-year Performance Based Restricted Stock Units
2018-12-31
Ordinary Shares
42000
42000
D
Employee Stock Option (right to buy)
15.17
2025-05-19
Ordinary Shares
35000
35000
D
Option to purchase ordinary shares
3.29
2024-06-27
Ordinary Shares
123431
123431
D
Employee Stock Option (right to buy)
8.00
2024-04-29
Ordinary Shares
90000
90000
D
Employee Stock Option (right to buy)
7.58
2027-05-23
Ordinary Shares
50000
50000
D
Multi-year Performance Based Restricted Stock Unit
2019-12-31
Ordinary Shares
60000
60000
D
Sold by Quotient Biodiagnostics Group Limited pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.09, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Deidre Cowan, Mr. Cowan's spouse, exercises sole voting and dispositive power over the shares.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.38 to $4.80, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.62, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
11,667 options vested on June 1, 2017 and remain exercisable, 11,667 options will vest on June 1, 2018, 11,666 options will vest on June 1, 2019.
Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $40.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
Each MRSU represents a contingent right to receive one share of Quotient ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $60.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
23,334 options have vested and remain exercisable, 11,666 options will vest on May 20, 2018.
All 123,431 options have vested and remain exercisable.
All 90,000 options have vested and remain exercisable.
The options will vest and become exercisable in three equal annual installments beginning on May 24, 2018.
Each MRSU represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $22.00 per share for 20 consecutive trading days during the period April 1, 2019 to December 31, 2019.
Chief Executive Officer and Chairman of the Board of Directors
/s/ Paul Cowan
2017-10-18